Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes (opens ClinicalTrials.gov)

The Gut Microbiome in Women With Polycystic Ovary Syndrome (opens ClinicalTrials.gov)

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes (opens ClinicalTrials.gov)

Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet (opens ClinicalTrials.gov)

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND) (opens ClinicalTrials.gov)

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks (opens ClinicalTrials.gov)

Study of the Cardiometabolic Effects of Obesity Pharmacotherapy (opens ClinicalTrials.gov)

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat (opens ClinicalTrials.gov)

Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities (opens ClinicalTrials.gov)

A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes (opens ClinicalTrials.gov)

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS) (opens ClinicalTrials.gov)

A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus (opens ClinicalTrials.gov)

Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities (opens ClinicalTrials.gov)

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin (opens ClinicalTrials.gov)

Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin (opens ClinicalTrials.gov)

Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes (opens ClinicalTrials.gov)

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes (opens ClinicalTrials.gov)

Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes (opens ClinicalTrials.gov)

Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood (opens ClinicalTrials.gov)

Life Style Modification Medical and Surgical Management in Patients With Obesity (opens ClinicalTrials.gov)